Κυριακή 15 Σεπτεμβρίου 2019


Antitumor and immunomodulatory effects of a novel multitarget inhibitor, CS2164, in mouse hepatocellular carcinoma models
As a novel orally active multitarget small molecule inhibitor, CS2164 has shown broad antitumor activities against several human tumor xenograft models in immune-compromised mice. However, the ability of CS2164 to modulate antitumor immunity in an immune-competent mouse tumor model remains undefined, although antiangiogenic treatment has been reported to affect immune cell infiltration and remodel the tumor immune microenvironment. In the present study, the subcutaneous and ascites hepatocellular...
Anti-Cancer Drugs - Current Issue
Sat Sep 14, 2019 09:56
RRAS2 knockdown suppresses osteosarcoma progression by inactivating the MEK/ERK signaling pathway
Aberrant function of RRAS2 drives malignant transformation in a various of cancers. However, little information exists on the function of RRAS2 in tumorigenesis of osteosarcoma. In this study, we investigated the effect of RRAS2 on osteosarcoma progression and its underlying mechanism. The gene expression level and prognostic power of RRAS2 in osteosarcoma were first investigated using the data from the Gene Expression Omnibus database. Then RNA interference was performed to silence the expression...
Anti-Cancer Drugs - Current Issue
Sat Sep 14, 2019 09:56
A novel small-molecule PI3K/Akt signaling inhibitor, W934, exhibits potent antitumor efficacy in A549 non-small-cell lung cancer
Small-molecule targeted antitumor drugs are considered to be a promising treatment that can improve the efficacy and reduce side effects. PI3K/Akt signaling pathway is constantly activated in various cancers. We recently synthesized a series of novel compounds of PI3K/Akt pathway inhibitors and found the most effective analog to be W934. In this study, we explored the in-vitro and in-vivo antitumor effects of W934 on A549 non-small-cell lung cancer cells and HCT116 colorectal cancer cells. In-vitro...
Anti-Cancer Drugs - Current Issue
Sat Sep 14, 2019 09:56
Oral metronomic cyclophosphamide in advanced ovarian cancer: long-lasting clinical response in an elderly frailty patient
Elderly patients with ovarian cancer are an increasing population and many of them are frailty with an increased risk of postoperative complications, chemotherapy intolerance and mortality. Metronomic chemotherapy is the chronic administration of low, equally spaced, doses of antineoplastic drugs with therapeutic efficacy and low toxicity. Oral metronomic cyclophosphamide has gained increasing interest in recent years in the treatment of patients with recurrent ovarian cancer. We report the case...
Anti-Cancer Drugs - Current Issue
Sat Sep 14, 2019 09:56
Salinomycin reduces epithelial–mesenchymal transition-mediated multidrug resistance by modifying long noncoding RNA HOTTIP expression in gastric cancer cells
Chemotherapy is the main treatment for advanced gastric cancer. However, the emergence of multidrug resistance (MDR) has become a major obstacle in chemotherapy in many tumors, including gastric cancer. Epithelial–mesenchymal transition (EMT), which is considered an important process in cancer development, also contributes toward tumor MDR. Salinomycin, an EMT blocker, shows broad-spectrum antitumor and chemosensitization properties. Here, we hypothesized that salinomycin could reverse the MDR of...
Anti-Cancer Drugs - Current Issue
Sat Sep 14, 2019 09:56
APLNR promotes the progression of osteosarcoma by stimulating cell proliferation and invasion
Osteosarcoma is the most common type of bone malignancies with a poor prognosis. In recent years, targeted therapy has shown great potential in the treatment of osteosarcoma, and more effective therapeutic targets for this disease need to be developed. APLNR is a seven transmembrane G-protein-coupled receptor expressed widely in multiple tissues. As has been reported, APLNR is involved in various physiological and pathological processes. Although APLNR plays a role in the development and progression...
Anti-Cancer Drugs - Current Issue
Sat Sep 14, 2019 09:56
Inhibition of laryngeal cancer stem cells by tetrandrine
Cancer stem cells play a fundamental role in the growth, metastasis, recurrence, and chemoresistance of cancers of various origins; therefore, targeting these cells may prospectively help to eradicate cancer cells from patients. In this study, the effect of tetrandrine on the proliferation of CD133-positive (CD133+) Hep-2 cells was examined to characterize its potential for targeting cancer stem cells in laryngeal cancer. The stem cell population of Hep-2 cells was isolated by magnetic-activated...
Anti-Cancer Drugs - Current Issue
Sat Sep 14, 2019 09:56
Tumour flare reaction in cancer treatments: a comprehensive literature review
In the past decade, tumour flare reaction (TFR) was considered as a new side effect associated with immunomodulatory agents (IMiDs) and as a condition of chronic lymphocytic leukaemia (CLL). However, this phenomenon is also observed with immune checkpoint inhibitors in solid tumours. It is still poorly understood and its incidence is underestimated. TFR has been associated with morbidity, therefore, early recognition and management of patients with TFR is critical. An exhaustive literature research...
Anti-Cancer Drugs - Current Issue
Sat Sep 14, 2019 09:56
A review of canakinumab and its therapeutic potential for non-small cell lung cancer
Inflammation is essential for our innate and adaptive immunity, but chronic inflammation can also be detrimental, playing a role in tumor development and subversion of host immunity. A multitude of proteins and cytokines are involved in chronic inflammation; interleukin-1β, in particular, has been recognized as a critical pro-inflammatory cytokine that can trigger a cascade of inflammatory mediators, promoting angiogenesis, tumor invasiveness, and metastasis. The inhibition of interleukin-1β with...
Anti-Cancer Drugs - Current Issue
Sat Sep 14, 2019 09:56
Issue Information
Cancer
Fri Sep 13, 2019 16:56
First person profile: Albert de la Chapelle, MD, PhD
Cancer
Fri Sep 13, 2019 16:56
Cervical cancer subtype less detectable by Papanicolaou testing
Cancer
Fri Sep 13, 2019 16:56
Some elderly survivors of 3 common cancers have an increased risk of brain metastases
Cancer
Fri Sep 13, 2019 16:56
PD-L1 and CD47 co-expression in pulmonary sarcomatoid carcinoma: a predictor of poor prognosis and potential targets of future combined immunotherapy
Abstract Purpose Combined immunotherapy with anti-programmed cell death-ligand 1 (PD-L1) and an inhibitor of cluster of differentiation 47 (CD47) have exhibited preliminary anti-tumor effect. Our study attempted to describe the PD-L1/CD47 expression status in pulmonary sarcomatoid carcinoma (PSC), and explore its survival impact and relevance with cytotoxic T lymphocytes and macrophages infiltration. ...
Journal of Cancer Research and Clinical Oncology
Sat Sep 14, 2019 03:00
Prevalence of dental caries in children and adolescents with type 1 diabetes: a systematic review and meta-analysis
Abstract Background Dental caries and type 1 diabetes are responsible for a large burden of global disease; however, the exact prevalence of dental caries among children and adolescents with type 1 diabetes remains controversial, and no quantitative meta-analysis exists. Thus, we performed a meta-analysis to evaluate the prevalence of dental caries among children and adolescents with type 1 diabetes. ...
Latest Results for BMC Oral Health
Sat Sep 14, 2019 03:00
A focus on culture and leadership
British Journal of Nursing, Volume 28, Issue 16, Page 1099-1099, September 2019.
Mark Allen Group: British Journal of Nursing: Table of Contents
Fri Sep 13, 2019 14:41
Let's share our concerns about the future
British Journal of Nursing, Volume 28, Issue 16, Page S3-S3, September 2019.
Mark Allen Group: British Journal of Nursing: Table of Contents
Fri Sep 13, 2019 14:41
Oral care in adults
British Journal of Nursing, Volume 28, Issue 16, Page 1054-1055, September 2019.
Mark Allen Group: British Journal of Nursing: Table of Contents
Fri Sep 13, 2019 14:41
From staff nurse to nurse consultant: Survival Guide part 4: Surviving as a senior clinical nurse
British Journal of Nursing, Volume 28, Issue 16, Page 1096-1096, September 2019.
Mark Allen Group: British Journal of Nursing: Table of Contents
Fri Sep 13, 2019 14:41
An end-of-year report card from NHS Resolution
British Journal of Nursing, Volume 28, Issue 16, Page 1094-1095, September 2019.
Mark Allen Group: British Journal of Nursing: Table of Contents
Fri Sep 13, 2019 14:41
Stop the noise
British Journal of Nursing, Volume 28, Issue 16, Page 1046-1046, September 2019.
Mark Allen Group: British Journal of Nursing: Table of Contents
Fri Sep 13, 2019 14:41
The use of voice-assisted technology to enhance self-care
British Journal of Nursing, Volume 28, Issue 16, Page 1092-1093, September 2019.
Mark Allen Group: British Journal of Nursing: Table of Contents
Fri Sep 13, 2019 14:41
Bullying: our dirty little secret
British Journal of Nursing, Volume 28, Issue 16, Page 1045-1045, September 2019.
Mark Allen Group: British Journal of Nursing: Table of Contents
Fri Sep 13, 2019 14:41
Tracheostomy care
British Journal of Nursing, Volume 28, Issue 16, Page 1060-1062, September 2019.
Mark Allen Group: British Journal of Nursing: Table of Contents
Fri Sep 13, 2019 14:41
Exploring individuals' perceptions of living with a stoma
British Journal of Nursing, Volume 28, Issue 16, Page S18-S22, September 2019.
Mark Allen Group: British Journal of Nursing: Table of Contents
Fri Sep 13, 2019 14:41
Neurological assessment in children and young people
British Journal of Nursing, Volume 28, Issue 16, Page 1056-1059, September 2019.
Mark Allen Group: British Journal of Nursing: Table of Contents
Fri Sep 13, 2019 14:41
Sexual function after stoma formation in women with colorectal cancer
British Journal of Nursing, Volume 28, Issue 16, Page S4-S15, September 2019.
Mark Allen Group: British Journal of Nursing: Table of Contents
Fri Sep 13, 2019 14:41
Older adults' self-advocacy in patient safety: a cross-sectional study
British Journal of Nursing, Volume 28, Issue 16, Page 1076-1084, September 2019.
Mark Allen Group: British Journal of Nursing: Table of Contents
Fri Sep 13, 2019 14:41
Setting up a nurse-led bowel ‘two week wait’ service
British Journal of Nursing, Volume 28, Issue 16, Page 1063-1068, September 2019.
Mark Allen Group: British Journal of Nursing: Table of Contents
Fri Sep 13, 2019 14:41
Clinical governance for ostomates at risk of peristomal skin complications
British Journal of Nursing, Volume 28, Issue 16, Page S24-S32, September 2019.
Mark Allen Group: British Journal of Nursing: Table of Contents
Fri Sep 13, 2019 14:41
Menopause and the NHS: caring for and retaining the older workforce
British Journal of Nursing, Volume 28, Issue 16, Page 1086-1090, September 2019.
Mark Allen Group: British Journal of Nursing: Table of Contents
Fri Sep 13, 2019 14:41
Using a frame of reference for talking to patients about death and dying
British Journal of Nursing, Volume 28, Issue 16, Page 1069-1075, September 2019.
Mark Allen Group: British Journal of Nursing: Table of Contents
Fri Sep 13, 2019 14:41
What are the challenges for nurses when providing end-of-life care in intensive care units?
British Journal of Nursing, Volume 28, Issue 16, Page 1047-1052, September 2019.
Mark Allen Group: British Journal of Nursing: Table of Contents
Fri Sep 13, 2019 14:41
BTK inhibitors synergize with 5‐FU to treat drug‐resistant TP53‐null colon cancers
Abstract Colorectal cancer is the fourth cause of death from cancer worldwide mainly due to the high incidence of drug‐resistance. During a screen for new actionable targets in drug‐resistant tumours we recently identified p65BTK ‐ a novel oncogenic isoform of Bruton's tyrosine kinase. Studying three different cohorts of patients here we show that p65BTK expression correlates with histotype and cancer progression. Using drug‐resistant TP53‐null colon cancer cells as a model we demonstrated that...
The Journal of Pathology
Fri Sep 13, 2019 19:09
Ex vivo and animal study of the blue diode laser, Tm fiber laser, and their combination for laparoscopic partial nephrectomy
Background and Objectives To evaluate the feasibility of using a novel blue diode laser (blue laser), a thulium fiber laser (Tm laser), and their combination as a directed‐energy surgical tool in laparoscopic partial nephrectomy (LPN). Study Design/Materials and Methods The blue laser emitting at 442 nm, the Tm laser emitting at 1,940 nm wavelengths, and the combination of them were tested. First, cutting and coagulative abilities of the lasers were characterized ex vivo on porcine kidney...
Lasers in Surgery and Medicine
Fri Sep 13, 2019 16:51
Mitogen‐activated protein kinase dependency in BRAF/RAS wild type melanoma: a rationale for combination inhibitors
Abstract Inhibitors targeting the mitogen‐activated protein kinase (MAPK) pathway and immune checkpoint molecules have dramatically improved the survival of patients with BRAF V600‐mutant melanoma. For BRAF/RAS wild type (WT) melanoma patients, however, immune checkpoint inhibitors remain the only effective therapeutic option with 40% of patients responding to PD‐1 inhibition. In the present study, a large panel of 10 BRAF V600‐mutant and 13 BRAF/RAS WT melanoma cell lines was analyzed to examine...
Wiley: Pigment Cell & Melanoma Research: Table of Contents
Fri Sep 13, 2019 19:03
Noninvasive cardiac psychophysiology as a tool for translational science with marmosets
affective reactivity relates to heart rate Abstract The importance of marmosets for comparative and translational science has grown in recent years because of their relatively rapid development, birth cohorts of twins, family social structure, and genetic tractability. Despite this, they remain understudied in investigations of affective processes. In this methodological note, we establish the validity of using noninvasive commercially available equipment to record cardiac physiology and compute...
American Journal of Primatology
Thu Sep 12, 2019 19:47
Density and distribution of western chimpanzees around a bauxite deposit in the Boé Sector, Guinea‐Bissau
Predicted abundance of nests overlaid with the location of the transects (black lines), location of clusters of nests (red dots), and future location of the mine (pink line). Ronde hill is shown by the green line and rivers are shown by blue lines. Abstract The Boé sector in southeast Guinea‐Bissau harbors a population of western chimpanzees (Pan troglodytes verus) that inhabits a mosaic of forest and savanna. The Boé sector contains a substantial bauxite deposit in a region called Ronde Hill,...
American Journal of Primatology
Fri Sep 13, 2019 19:44
Supplemented howler monkeys eat less wild fruits, but do not change their activity budgets
Influence of food supplementation on the diet and activity budget of adult brown howler monkeys.Abstract Research on the influence of food supplementation on primate behavior has focused on terrestrial and semiterrestrial species. Its effects on highly arboreal species are poorly known. We assessed the influence of food supplementation on the feeding behavior and activity budget of four adult female and two adult male brown howler monkeys (Alouatta guariba clamitans) belonging to two groups...
American Journal of Primatology
Fri Sep 13, 2019 19:44

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου